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Abstract
Introduction Osteoarthritis is influenced by genetic and
environment factors, including mechanical stress; however, the
relationship between running and the development of
osteoarthritis remains a matter of controversy. We investigated
whether osteoarthritic change could be obtained in a rat
strenuous running model, whether serum keratan sulfate in rats
could be detected by HPLC and was associated with onset or
progression of osteoarthritis, and whether hyaluronan injection
suppressed development of osteoarthritis and elevation of
serum keratan sulfate.
Methods Wistar rats were forced to run 30 km in 6 weeks on a
treadmill machine. Articular cartilage of the knees was evaluated
macroscopically and immunohistologically. Serum keratan
sulfate was examined every week by HPLC. The effect of weekly
knee injection of hyaluronan was also investigated.
Results Cartilage surfaces stained with India ink became
irregular, metachromasia by safranin-O staining appeared to be
almost lost, and Mankin's score significantly worsened after 30
km of running. Serum keratan sulfate in rats was detected by
HPLC and transiently increased (peaked at 3 to 4 weeks) along
with depletion of keratan sulfate in cartilage tissue. Hyaluronan
treatment suppressed morphological progression of
osteoarthritis and elevation of serum keratan sulfate.
Conclusion Rat strenuous running induced osteoarthritis.
Serum keratan sulfate was associated with progression of
osteoarthritis. Weekly intraarticular injection of hyaluronan
controlled the development of osteoarthritis, and the effect was
reflected by serum keratan sulfate.
Introduction
Osteoarthritis is the most common cause of joint pain and loss
of mobility in older people. Osteoarthritis is influenced by
genetic and environmental factors, including mechanical
stress. To overcome difficulties in studying osteoarthritis in
humans, animal models have been developed, such as spon-
taneous models in aging animals, genetically modified mice, as
well as surgically, enzymatically or chemically induced models
[1,2]. The use of strenuous running helps simulate long-term
stress on weight-bearing joints. This model does not require
surgical procedures or injection of reagents, and therefore it
can detect subtle symptoms of osteoarthritis. The relationship
between running and the development of osteoarthritis, how-
ever, remains a matter of controversy [3-7]. The first purpose
of our study was to examine whether osteoarthritic change
could be obtained in a rat strenuous running model.
Keratan sulfate is a glycosaminoglycan that is specifically dis-
tributed in the extracellular matrix of the cartilage, cornea, and
brain [8]. Serum keratan sulfate was measured using an ELISA
BSA = bovine serum albumin; ELISA = enzyme-linked immunosorbent assay; HPLC = high-performance liquid chromatography; PBS = phosphate-
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in 1985, and its usefulness as a marker of osteoarthritis was
proposed; however, serum keratan sulfate did not correlate
with the X-ray grading [9,10]. In 2007 Wakitani and col-
leagues measured serum keratan sulfate using HPLC, which
has been reported to be more sensitive and more accurate
than ELISA [11], and demonstrated a higher value of serum
keratan sulfate in patients with early-stage damage of the artic-
ular cartilage undetectable by X-ray imaging [12]. These
results indicate a more important usefulness of HPLC for
serum keratan sulfate. On the other hand, recent analysis for
serum keratan sulfate in rats and mice has scarcely been
investigated possibly due to one paper describing the
absence of keratan sulfate in skeletal tissues of mouse and rat
[13]. In this paper, keratan sulfate was examined by immuno-
histochemistry using the monoclonal antibody MZ15; how-
ever, keratan sulfate expression in rat cartilage was detected
using the other antibodies 5D4 [14] and EFG-11 [6]. The sec-
ond study purpose was to investigate serum keratan sulfate in
rats by HPLC and its association with onset or progression of
osteoarthritis.
Hyaluronan is also a glycosaminoglycan. In articular cartilage,
hyaluronan and aggrecan form large aggregates, bind huge
amounts of water, and are responsible for the resilience of car-
tilage. Intraarticular injection of hyaluronan has been wildly uti-
lized clinically as pain relief for the early stage of knee
osteoarthritis [15,16]. Several studies have reported that
hyaluronan has beneficial effects on cartilage during develop-
ment of osteoarthritis [17]. The third study objective was to
analyze serum keratan sulfate sequentially after hyaluronan
injection in a rat strenuous running model.
Materials and methods
Animals and strenuous running
Wistar rats 16 to 18 weeks of age (Sankyo Labo Service,
Tokyo, Japan) were used for the experiments. All experiments
were conducted in accordance with the institutional guide-
lines for the care and use of experimental animals. Rats were
divided into three groups: no running group (0 km, n = 5); only
strenuous running group (30 km, n = 8); and strenuous run-
ning and hyaluronan injection group (15 km, n = 3; 30 km, n =
5).
For strenuous running exercise, a rodent treadmill machine
(MK-680R5; ME Service., Tokyo, Japan) was used with a 5%
incline (Figure 1a). The MK-680R5 has been designed to com-
pulsively make animals exercise by electrical shock delivered
to the animals without failure by the adoption of a shock gen-
erator scrambler. The rats were acclimated to the treadmill by
gradually increasing the running speed and time as follows:
day 1, 10 minutes at 10 m/min; day 2, 15 minutes at 12 m/min;
day 3, 20 minutes at 15 m/min; day 4, 30 minutes at 18 m/min;
and day 5, 35 minutes at 20 m/min. On day 8 and thereafter,
the rats were forced to run for 55 minutes a day at 20 m/min,
with the first 10 minutes consisting of a 12 m/min warm-up.
Rats ran 30 km in 6 weeks, as shown in Figure 1b[18]. For the
hyaluronan injection group (n = 5), 100 μl hyaluronan (average
molecular weight = 8 × 105 Da; Seikagaku Corp., Tokyo,
Japan) containing 1 mg in formulated concentrate was
injected into the right knee. The injections were performed ini-
tially at 5 days and every 1 week thereafter under anesthesia
of 10 mg sodium pentobarbital (Dainippon Sumitomo Pharma,
Osaka, Japan) by intraperitoneal injections. As a control for
hyaluronan treatment, saline or PBS was not injected into the
left knee to avoid the possibility that they might enhance oste-
oarthritis [19,20].
Macroscopic observation
Femoral and tibial condyles were carefully dissected sepa-
rately without damaging the cartilage surface, and were then
stained with India ink to identify the location, size and severity
of cartilage degeneration. Macroscopic pictures were taken
Figure 1
Method for rat strenuous running Method for rat strenuous running. (a) Rodent treadmill machine designed to compulsively make rats run. (b) Protocol for running exercise. Rats were 
forced to run 30 km in 6 weeks. For the hyaluronan group, the injection was performed initially at 5 days, followed by every 7 days (arrows).Available online http://arthritis-research.com/content/10/1/R13
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using a specification MPS-7 (Sugiura Laboratory Inc., Tokyo,
Japan), a dedicated medical photography platform. Digital
images were taken using a Nikon Coolpix 4500 digital camera
(Nikon, Tokyo, Japan).
Histology
The rats were sacrificed with an overdose of sodium pentobar-
bital. Both femurs and tibias were fixed in 4% paraformalde-
hyde at pH 7.4 for 3 days, were decalcified in 20%
ethylenediamine tetraacetic acid solution for 21 days, and
were then embedded in paraffin wax. Femurs and tibias were
sectioned sagittally at 5 μm and stained with safranin-O. His-
tological sections were visualized using an Olympus IX71
microscope (Olympus, Tokyo, Japan). Each section was eval-
uated with the Mankin's histological grading system (Mankin's
score: 0 to 14) for articular cartilage degeneration [21].
Immunohistochemistry
Sections were deparaffinized, washed in PBS, and pretreated
with 0.4 mg/ml proteinase K (DAKO, Carpinteria, CA, USA) in
Tris–HCl buffer for 15 minutes at room temperature for optimal
antigen retrieval. Endogenous peroxidases were quenched
using 0.3% hydrogen peroxide in methanol for 20 minutes at
room temperature. The sections were rinsed once in PBS for
5 minutes and were briefly blocked with 10% normal horse
serum (Vector Laboratories, Burlingame, CA, USA) to avoid
nonspecific binding of the antibody. The sections were then
incubated in monoclonal anti-keratan sulfate antibody (5-D-4,
1:100 dilution with PBS containing 1% BSA; Seikagaku
Corp.) or anti-mouse monoclonal antibody against human type
II collagen (1:200 dilution with PBS containing 1% BSA; Dai-
ichi Fine Chemical, Toyama, Japan) at room temperature for 60
minutes. After rinsing in PBS, the tissues were incubated with
biotinylated horse anti-mouse IgG secondary antibody (Vector
Laboratories) for 30 minutes at room temperature. The slides
were again immersed in PBS and were incubated for another
30 minutes with Vectastain ABC reagent (Vector Laborato-
ries). Finally, the sections were shortly counterstained with
hematoxylin, dehydrated and mounted in a xylol-soluble mount
(Vitro-Clud; R. Langenbrinck, Emmendingen, Germany)
[12,22,23].
Keratan sulfate concentration
To avoid circadian variation of keratan sulfate in serum, blood
was collected at between 3:00 and 4:00 pm, 1 hour after fin-
ishing strenuous running. Approximately 500 μl blood was
aspirated with a 27-gauge needle from the tail vein of the rats.
The blood was kept at 4°C for 2 hours and was centrifuged at
2,000 rpm for 15 minutes at 4°C. The serum was separated,
allocated into 100 μl, and kept frozen at -70°C. To avoid an
influence of freeze–thaw, the serum was used for the analyses
without refreezing. Every rat started strenuous running on
Monday and had its blood aspirated every Friday. Each 200 μl
serum was diluted with 800 μl distilled water, digested with
100 μl of 2.0% Actinase E (Kaken Pharmaceutical., Tokyo,
Japan) at 55°C for 24 hours, and was heated at 100°C for 10
minutes. The whole solution was applied to Q Sepharose 0.15
M sodium chloride (GE Healthcare UK Ltd., Little Chalfont,
Buckinghamshire, UK), and was extracted with 50 mM Tris–
HCl buffer (pH 8.6) containing 2 M sodium chloride. The
extracted material was desalinated with PD-10 (GE Health-
care), dried, and dissolved again by 0.2 ml distilled water.
Then 1 mU Keratanase II (Seikagaku Corp.) was added, fol-
lowed by addition of 40 μl of 100 mM sodium acetate buffer
(pH 6.0), and the mixture was incubated at 37°C for 3 hours.
The sample was ultrafiltered using an Ultrafree C3GC system
whose molecular weight cutoff was 10,000 daltons (Japan
Millipore, Tokyo, Japan). The filtrate, which contained monosul-
fate disaccharide and disulfate disaccharide derived from
keratan sulfate, was analyzed by HPLC with the column
packed with polyamine-bound silica (YMC gel PA-120; YMC
Ltd, Kyoto, Japan). The monosulfate disaccharide and disul-
fate disaccharide were eluted with a gradient of 0 to 100 mM
sodium sulfate for 45 minutes at a flow rate of 0.5 ml/min. To
elute from the column, 100 mM sodium tetraborate buffer (pH
9.0) containing 1% 2-cyanoacetamide was added at a flow
rate of 0.5 ml/min. The mixture was passed through poly(ether
ether ketone) (PEEK; Victrex, Lancashire, UK) tubing with a
0.5 mm diameter and a 10 m length in a dry fluoromonitor
(excitation, 331 nm; emission, 383 nm). The area of each peak
corresponding to monosulfate disaccharide and to disulfate
disaccharide was calculated by Borwin-HSS2000 software
(Jasco, IJsselstein, Netherlands) and was converted to the
amount of the corresponding disaccharides against the area
of standard monosulfate disaccharide and disulfate disaccha-
ride (Seikagaku Corp.) [12].
Statistical analysis
The StatView 5.0 program (SAS Institute, Cary, NC, USA) was
used for statistical analyses. P < 0.05 was considered statis-
tically significant.
Results
Degeneration of articular cartilage
Strenuous running exercise affected the articular cartilage.
The cartilage surfaces of both the lateral femoral condyle and
the lateral tibial plateau were irregular after 30 km of strenuous
running (Figure 2). A weekly intraarticular hyaluronan injection
helped maintain the smoothness of the surface of the articular
cartilage (Figure 2). Histological analyses demonstrated that
30 km of strenuous running induced depletion of the articular
cartilage matrix (Figure 3a) and worsened the Mankin's score
(Figure 3b). Hyaluronan treatment suppressed the degenera-
tion of the articular cartilage (Figure 3c).
Serum concentration of keratan sulfate
Sequential serum concentrations of keratan sulfate were
examined. In the control group (the only strenuous running
group), the concentration transiently peaked at 3 to 4 weeksArthritis Research & Therapy    Vol 10 No 1    Tang et al.
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(Figure 4, left). Hyaluronan treatment appeared to suppress
the keratan sulfate concentration (Figure 4, center). The aver-
age of the maximum keratan sulfate concentration during the
5-week period in each rat in the hyaluronan group was signifi-
cantly lower than that in the control group (Figure 4, right).
Immunohistochemical analysis
Keratan sulfate and type II collagen were expressed in carti-
lage of rats before strenuous running and were still present at
3 weeks after 15 km of strenuous running. Keratan sulfate
expression decreased and was hardly observed at 6 weeks
after 30 km of strenuous running in the control group. The type
II collagen-positive area decreased along with the cartilage
area, but the expression could be still observed in the remain-
ing cartilage in the control group after 30 km of strenuous run-
ning. Hyaluronan treatment suppressed the loss of keratan
sulfate and type II collagen after 30 km of strenuous running
(Figure 5).
Discussion
Running exercise may injure articular cartilage – although
there are also studies suggesting that it has no adverse effects
on articular cartilage, and that the effects are mostly beneficial
[5]. These studies indicate that the influences of physical exer-
cise are bidirectional, the net result dependent on the degree
of joint loading. Excessive running seems to lead to a higher
incidence of osteoarthritis, whereas moderate running is either
noncontributory in joint degeneration or beneficial in
decreasing the risk of osteoarthritis in animals. Excessive run-
ning load is expected to markedly exceed the animals' normal
Figure 2
Macroscopic observation Macroscopic observation. Femoral and tibial articular cartilage stained with India ink. Cartilage lesions are indicated by arrowheads. Lat, lateral; Med, 
medial.Available online http://arthritis-research.com/content/10/1/R13
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physiological running activities. Pap and colleagues first
reported development of osteoarthritis in the knee joints of rats
after strenuous running exercise [3]. They stimulated the rats
intracranially to motivate them to run on a running wheel. In our
present study, we used a rodent treadmill machine to motivate
Wistar rats running by external electrical stimulation to their
tail. We demonstrated development of osteoarthritis of the
knee joint of nongenetically modified rats. This simple method
without requiring specific surgery will be useful for analyses of
subtle symptoms such as serum cartilage marker in the
present study.
Progression of osteoarthritis is likely to result primarily from an
imbalance between cartilage degradation and repair. Biologi-
cal markers in the blood might provide relevant information
more rapidly than imaging techniques such as radiography
and magnetic resonance imaging can, and should contribute
to our understanding of mechanisms that underlie the clinical
efficacy of osteoarthritis treatments [24]. As osteoarthritis
affects mainly the cartilage, structural molecules or fragments
derived from cartilage tissues could be candidate serum carti-
lage markers for osteoarthritis. These tissues might also
include molecules that play a role in metabolic processes,
Figure 3
Histological analyses for cartilage legions Histological analyses for cartilage legions. (a) Representative histologies of the lateral femoral condyle and the lateral tibial plateau stained with 
safranin-O. Scale bar = 200 μm. (b) Influence of running 30 km on cartilage. Mankin's score of the right knee in rats after 30 km of strenuous running 
without hyaluronan injection was compared with that in control rats without strenuous running or hyaluronan injection. Data expressed as the mean ± 
standard deviation (n = 5). *P < 0.01, Mann–Whitney U test. (c) Effect of hyaluronan on cartilage. Mankin's score for cartilage legions. Rats were 
forced to run 30 km in 6 weeks. Hyaluronan was injected each week into the right knee. Nothing was injected into the left knee. Both sides of the 
knees were compared. Mankin's score expressed as the mean ± standard deviation (n = 5). **P < 0.05, Wilcoxon signed rank test.Arthritis Research & Therapy    Vol 10 No 1    Tang et al.
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Figure 4
Serum concentration of keratan sulfate Serum concentration of keratan sulfate. Blood was collected every week at 0 to 5 weeks. Sequential serum concentrations of keratan sulfate are 
shown individually in the control group (left panel) and in the hyaluronan group (center panel). Maximum values of the concentrations are plotted, and 
the average values are shown in the right panel (control, n = 8; injection of hyaluronan, n = 5). **P < 0.05 by Mann–Whitney U test.
Figure 5
Immunohistochemical analyses Immunohistochemical analyses. Representative histologies of the lateral femoral condyle and the lateral tibial plateau immunostained with (a) keratan 
sulfate (KS) and (b) type II collagen (COL2). Scale bar = 200 μm.Available online http://arthritis-research.com/content/10/1/R13
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such as cytokines, proteases, and enzyme inhibitors. In human
subjects, serum keratan sulfate increased after exercise in
healthy athletes [25] and in patients with early-stage osteoar-
thritis [12]. Furthermore, keratan sulfate was specifically dis-
tributed in the cartilage, cornea, and brain [8]. We therefore
focused on serum keratan sulfate as an osteoarthritis marker
in this rat model.
In the present study we demonstrated that serum keratan sul-
fate rapidly increased when Wistar rats ran approximately 15
to 20 km. Interestingly, serum keratan sulfate rapidly
decreased thereafter. According to our immunohistochemical
analysis, keratan sulfate expression was still stable when rats
ran 15 km and disappeared when rats ran 15 to 20 km. We
speculate a possible mechanism as follows. Daily strenuous
exercise was extremely difficult for rats, and much of the result-
ing mechanical stress was absorbed by their joints. This
caused transient joint cartilage degradation. Proteoglycan
fragments, which are detached by mechanical stress to the
cartilage, were ejected from the synovial cavity into the blood
through the lymphatic system, and consequently serum kera-
tan sulfate increased. Keratan sulfate in the affected cartilage
also rapidly disappeared after keratan sulfate degraded once,
and then serum keratan sulfate decreased rapidly.
Uebelhart and colleagues previously reported that serum kera-
tan sulfate increased sharply 1 day after injection of chymopa-
pain into the knee joint in rabbits [26]. The serum keratan
sulfate also sharply decreased, and these changes were
accompanied by depletion of proteoglycans evaluated by
safranin-O stained histology. Although the cartilage matrix
degradated in a much shorter period and keratan sulfate
expression was not analyzed spatially or temporally in their
model, their results correspond with our results in that serum
keratan sulfate levels increased predictably following acute
loss of proteoglycan.
For evaluation of keratan sulfate, we digested rat serum with
Keratanase II and then measured the sum of monosulfate and
disulfate disaccharides derived from keratan sulfate by HPLC.
Rat serum may contain nonsulfate disaccharides, whose level
may be affected by degeneration of the articular cartilage. In
the present study, we cannot answer how the error of ignoring
nonsulfated disaccharides could affect the measurement of
the total keratan sulfate concentration in rat serum. We could,
however, demonstrate that sulfated disaccharides derived
from keratan sulfate in rat serum transiently increased in the
early stages of osteoarthritis.
Our immunohistological analysis has shown that strenuous
running led to damage of type II collagen in 6 weeks. We
examined sequentially the serum concentration of C2C, spe-
cific for the destruction of type II collagen by MMP-1, MMP-8,
and MMP-13. We could not, however, detect C2C in rat
serum in 6 weeks (data not shown).
Previous in vitro and in vivo studies indicate that exogenous
hyaluronan can enhance proteoglycan synthesis and can pre-
vent its release from the cell matrix [16,27]. Hyaluronan also
suppresses the production and activity of proinflammatory
mediators and proteases as well as altering the function of
immune cells [17]. Intraarticular hyaluronan injection can
reduce painful symptoms and improve general activities and
joint mobility [28]. The mechanism may be that intraarticular
hyaluronan injection causes less friction between articular car-
tilages, and improves joint comeback and reduces pain, thus
providing good balance of the knee joint for running exercise.
Lammi and colleagues investigated the distribution of endog-
enous hyaluronan in full thickness defects of rat articular carti-
lage [6]. In normal articular cartilage, hyaluronan was stained
mainly around the chondrocytes. During repair, strong hyaluro-
nan staining was observed in loose mesenchymal tissue and
in an area undergoing endochondral ossification. The high
level of endogenous hyaluronan, however, could not induce
the repair of osteochondral defect. Interestingly, remarkably
strong staining for hyaluronan was demonstrated in areas that
were simultaneously devoid of staining for keratan sulfate [6].
These results may show the possibility that the effect of
endogenous hyaluronan is insufficient to repair the cartilage
defect, losing keratan sulfate expression.
The present in vivo study demonstrated that intraarticular
injection of hyaluronan suppressed progression of osteoarthri-
tis. One of the mechanisms was to prevent release of keratan
sulfate from the cartilage matrix. This could be monitored by
the concentration of keratan sulfate in serum.
Conclusion
Osteoarthritic change could be obtained in a rat strenuous
running model. Rat serum keratan sulfate was detected by
HPLC and transiently increased along with depletion of kera-
tan sulfate in cartilage tissue. Hyaluronan treatment sup-
pressed development of osteoarthritis, and the effect was
reflected by serum keratan sulfate.
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